Twitter

Archive for October 6th, 2011


Super Ally’s 30-day run raises 20k

… and neighbour Pat Beausang. Pat, an NHS Forth Valley consultant, lost his battle with leukaemia in 2009 aged just 43. Also on the esplanade were representatives of Leukaemia and …

Read More...

Photos: Girl, fifteen years old, fighting cancer celebrates birthday in Nicaragua

… no / Associated Press ) – In this photo taken Tuesday Sept. 20, 2011, leukemia patient Maria Jose Martinez, 15, sits in Dr. Mercedes Arguellos office in the oncology …

Read More...

Leukemia: New mutations in leukemia: Researchers found mechanism that can help design future therapies

… the proliferation and differentiation of T-cells. The identification and study of mutations found in leukemia patients is particularly important to help develop more efficient and targeted therapies. Researchers now …

Read More...

Research and Markets: Acute Lymphocytic Leukemia (ALL) Therapeutics – Pipeline Assessment and Market Forecasts to 2017

… Research and Markets (http://www.researchandmarkets.com/research/1f417a/acute_lymphocytic) has announced the addition of GlobalData’s new report “Acute Lymphocytic Leukemia (ALL) Therapeutics – Pipeline Assessment and Market Forecasts to 2017″ to their offering. Acute …

Read More...

Swabbing Cheeks to Save Lives: The Gift of Bone Marrow

… Boston Childrens for some tune ups, but things are looking good. Alexs journey with leukemia began in April 2008, when he was 13. In his personal blog, he chronicles …

Read More...

Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA)

Conditions :   Hepatic Fibrosis;   Hepatocellular Carcinoma Intervention :   Procedure: Magnetic resonance elastography and liver biopsy Sponsor :   Seoul National University Hospital Not yet recruiting – verified October 2011

Read More...

Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

Conditions :   Solid Tumour;   Adenocarcinoma of the Colon;   Adenocarcinoma of the Pancreas Intervention :   Drug: CEP-37250/KHK2804 Sponsors :   Kyowa Hakko Kirin Pharma, Inc.;   Cephalon Not yet recruiting – verified October 2011

Read More...

Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors

Condition :   Solid Tumors Interventions :   Drug: MM-121 (SAR256212) plus Gemcitabine;   Drug: MM-121 (SAR256212) plus Carboplatin;   Drug: MM-121 (SAR256212) plus Pemetrexed Sponsors :   Merrimack Pharmaceuticals;   Sanofi-Aventis US, Inc. Recruiting – verified October 2011

Read More...

A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers

Conditions :   Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Cancer Interventions :   Drug: MM-121 (SAR256212) + Paclitaxel;   Drug: Paclitaxel Sponsors :   Merrimack Pharmaceuticals;   Sanofi-Aventis US, Inc. Not yet recruiting – verified October 2011

Read More...

Adaptation of the American Cancer Society (ACS) Early Detection of Prostate Cancer Patient Decision Aid for Spanish Speaking Men

Conditions :   Prostate Cancer;   Cancer Interventions :   Behavioral: Post-Test Questionnaire;   Behavioral: Interviews;   Behavioral: Focus Groups Sponsors :   M.D. Anderson Cancer Center;   Department of Defense Not yet recruiting – verified October 2011

Read More...